Aclaris Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 172.52, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Aclaris Therapeutics Inc in Mar 31 2026 quarter, has decreased to 2 days, compared to 5 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 379 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2423, from overall ranking in the fourth quarter 2025 at 3071.

What is Receivable Turnover Ratio?
What is Aclaris Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACRS Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-40.31 %	-32.98 %
Y / Y Revenue Change	37.18 %	-85.94 %	-24.09 %	-35.76 %	-39.32 %
Receivable Turnover Ratio (TTM)	172.52	70.5	82.63	60.77	57.53
ACRS's Total Ranking	# 2423	# 3071	# 121	# 2781	# 229
Accounts Receivable average collection period days	2	5	4	6	6
Seq. Receivable Change	-	-	-	-22.4 %	-21.38 %
Seq. Revenue Change	54.13 %	-60.75 %	85.65 %	22.13 %	-84.2 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 135
Healthcare Sector	# 380
Overall Market	# 2423

Receivable Turnover Ratio Statistics
High	Average	Low
0.17	0.07	-0.03
(Jun 30 2024)		(Sep 30 2020)

ACRS Company Profile • Back to ACRS Efficiency Comparisons • Compare ACRS Receivables Turnover Ratio to its Competitors

Financial Statements
Aclaris Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit ACRS's Balance sheet
Aclaris Therapeutics Inc 's Sales TTM	$ 8 Millions	Visit ACRS's Income Statement
Sources of ACRS's Revenues		Visit ACRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACRS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACRS's Growth Rates	ACRS's Roa	ACRS's Inventory Turnover Ratio	ACRS's Dividend Comparisons
ACRS's Profitability Ratios	ACRS's Roi	ACRS's Asset Turnover Ratio	ACRS's Dividend Growth
ACRS's Valuation Ratios	ACRS's Roe	ACRS's Financial Strength Ratios	ACRS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-29T17:35:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.